Month: August 2025

Offering Structured to Accelerate Streamex’s Operational Build-Out, Strategically Allocated with No Warrants Los Angeles, CA, Aug. 15, 2025 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), a gold tokenization infrastructure company, today announced the closing of its previously announced underwritten public offering, including a group of technology and mining thought leaders. The offering consisted of 3,852,149 shares of common stock at a public offering price of $3.90 per share with no pre-funded warrants. The gross proceeds from the offering, before deducting underwriter discounts and commissions and other estimated offering expenses were approximately $15,023,381. The Company intends to use the net proceeds from the...

Guangzhou, China, Aug. 15, 2025 (GLOBE NEWSWIRE) — Youxin Technology Ltd (Nasdaq: YAAS) (the “Company” or “Youxin Technology”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digitally transform their businesses, today announced that it received two staff determination notices (the “Notice(s)”) from the Listings Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on August 13, 2025. The Notices notify the Company that it is not in compliance with the minimum bid price requirement as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq, and pursuant to Listing Rule 5550(b)(2), it is required to maintain a minimum Market Value of Listed Securities (“MVLS”) of $35 million for continued listing on the Nasdaq Capital Market...

Ness Ziona, Israel, Aug. 15, 2025 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, announced today that it plans to conduct a reverse share split of the Company’s outstanding ordinary shares, no par value per share, at a ratio of 1-for-7 which is expected to be implemented at market open on the Tel-Aviv Stock Exchange on August 24, 2025 and on the Nasdaq Capital Market on August 25, 2025. There will be no change to the existing ratio of the number of ordinary shares represented by the Company’s American Depositary Shares (“ADSs”). However, as a result of the reverse share split, the ADS price is expected to increase proportionally, although the Company can give no assurance that the ADS price after the reverse share split will be...

SHANGHAI, Aug. 15, 2025 (GLOBE NEWSWIRE) — Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced that the board of directors received a preliminary non-binding proposal letter, dated August 13, 2025, from Hillhouse Investment Management, Ltd. (together with its affiliates, “Hillhouse”) to acquire all of the outstanding ordinary shares of the Company that are not already beneficially owned by Hillhouse or the Management Members (as defined below) for US$1.77 per ADS or US$0.885 per share in cash, subject to the acceptance by the Management Members of the similar rollover arrangement in the Merger Agreement (as defined below). On August 1, 2025, the Company announced that it had entered into a definitive Agreement and Plan of...

League commissioners nationwide can secure their spot early and score perks like draft kits, food and drink specials, and exclusive kickback cards DALLAS, Aug. 15, 2025 (GLOBE NEWSWIRE) — Twin Peaks Restaurant, the ultimate sports lodge, is a point up on fantasy football this season with the launch of its first nationwide online draft party table reservation system in addition to exclusive offers for league commissioners. Through Sept. 4, fans can book tables at their local Twin Peaks and score exclusive perks, including:Twin Peaks Draft Kit with a draft board, player stickers, and more Food and drink specials straight from Twin Peaks’ scratch kitchen and bar $50 kickback card* for the commissioner $5 kickback card* for every guest to use on a future visit“With football season always delivering big for us, we wanted to raise...

Transaction Expected to Close in the Coming Days Combined Company to be Named YD Bio Limited and Expectedto Trade on Nasdaq Under Ticker Symbol “YDES” IRVING, Texas, Aug. 15, 2025 (GLOBE NEWSWIRE) — Breeze Holdings Acquisition Corp. (“Breeze”) (OTCQX: BRZH; OTCQB: BRZHR, BRZHW), a publicly traded special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination (the “Business Combination”) with YD Biopharma Limited (“YD Biopharma”), a Taiwan–based biopharmaceutical company dedicated to developing, manufacturing and commercializing innovative vaccines and therapeutic biologics for infectious diseases and other indications. The special meeting of stockholders was held on August 14, 2025. Holders of 3,128,495 shares were represented in person or by proxy, constituting...

DALLAS, Aug. 15, 2025 (GLOBE NEWSWIRE) — HF Sinclair Corporation (NYSE and NYSE Texas: DINO) (the “Corporation”) today announced the pricing terms for its previously announced cash tender offer (the “Tender Offer”) to purchase any and all of its outstanding notes listed in the table below (collectively, the “Notes” and each a “Series” of Notes). All other terms and conditions of the Tender Offer remain unchanged and are described in the Offer to Purchase, dated August 11, 2025 (the “Offer to Purchase”). Capitalized terms used in this news release and not defined herein have the meanings given to them in the Offer to Purchase. The applicable consideration to be paid in the Tender Offer for each Series of Notes accepted for purchase was determined by reference to the applicable fixed spread specified for such Series of Notes over...

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years Fibromyalgia is a chronic pain condition that affects more than 10 million adults in the U.S. who are mostly women Two Pivotal Phase 3 studies demonstrated Tonmya significantly reduced fibromyalgia pain compared to placebo; generally well tolerated Commercial availability of Tonmya is expected in the fourth quarter Company to host webcast and conference call on Monday August 18, 2025 at 8:30 AM ET CHATHAM, N.J., Aug. 15, 2025 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) approved Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults. Tonmya is a first-in-class,...

Gross Profit Rises 462% to $6.7 Million Net Income from Continuing Operations Improved by $26.6 Million to $23.7 Million Revenue for First Half of 2025 Increased 382% to $22.9 Million, a $18.1 Million Increase from Prior Year Generated $973,606 in Positive Cash Flow from Continuing Operations in First Half of 2025, Marking a Significant Milestone Reaffirms 2025 Guidance for Net Income of ~$1.3 Million on Revenue of Over $45 Million; Projects 2026 Net Income of ~$5.0 Million on Revenue of More than $60 Million NEW YORK, NY, Aug. 15, 2025 (GLOBE NEWSWIRE) — 1847 Holdings LLC (“1847” or the “Company”) (Ticker: EFSH), a holding company specializing in identifying overlooked, deep-value investment opportunities in middle market businesses, today announced financial results for the three months ended June 30,...